Technetium, as they called it, was the last of elements 1-92 to be tracked down, and in fact it had to be synthesized rather than isolated from naturally occurring sources.

Global shortages of nuclear chemical needed for cancer scans will see patients’ appointments cancelled, minister warns ...

Technetium-99m radiopharmaceuticals will continue to have a significant impact in several areas of nuclear medicine. This publication is intended to provide a broad overview of the current status of ...

Health Minister Mike Nesbitt said the severe UK-wide shortage of radioisotopes, used for diagnosing cancers and organ scans, ...

Cancer and heart patients in Northern Ireland are likely to have their treatment delayed or cancelled due to a “severe ...

Telix Pharmaceuticals leverages a novel theranostic approach, offering a unique risk-reward model in the challenging biotech ...

Technetium-99m (99mTc) is used in approximately 85% of diagnostic imaging procedures in nuclear medicine worldwide. Interruptions in the supply of molybdenum (99Mo), which is used to produce 99mTc, ...

CMS issued the 2025 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Final Rule Nov. 1, with several new elements for hospital outpatient ...

European research reactors play a crucial role in producing medical radioisotopes using nuclear fuel and are transitioning to ...

Shortages of a radioactive isotope required for diagnostic imaging and procedures, as well as some surgeries, have led to patients facing appointment cancellations throughout the UK, the Royal College ...

Researchers at an Iranian technology company have succeeded in obtaining the instructions for the production of a radioactive ...